{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:31:03Z","timestamp":1790692263006,"version":"4.1.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T00:00:00Z","timestamp":1626739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma (GBM), one of the most aggressive tumors of the brain, has no effective or sufficient therapies. Identifying robust biomarkers for the response to immune checkpoint blockade (ICB) therapy, a promising treatment option for GBM patients, is urgently needed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      We comprehensively evaluated lncRNA m\n                      <jats:sup>6<\/jats:sup>\n                      A modification patterns in m\n                      <jats:sup>6<\/jats:sup>\n                      A-sequencing (m\n                      <jats:sup>6<\/jats:sup>\n                      A-seq) data for GBM tissues and systematically investigated the immune and stromal regulators of these m\n                      <jats:sup>6<\/jats:sup>\n                      A-regulated lncRNAs. We used the single-sample gene-set enrichment analysis (ssGSEA) algorithm to investigate the difference in enriched tumor microenvironment (TME) infiltrating cells and the functional annotation of HSPA7 in individual GBM samples. Further, we validated that HSPA7 promoted the recruitment of macrophages into GBM TME\n                      <jats:italic>in vitro<\/jats:italic>\n                      , as well as in our GBM tissue section. We also explored its impact on the efficacy of ICB therapy using the patient-derived glioblastoma organoid (GBO) model.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Here, we depicted the first transcriptome-wide m\n                      <jats:sup>6<\/jats:sup>\n                      A methylation profile of lncRNAs in GBM, revealing highly distinct lncRNA m\n                      <jats:sup>6<\/jats:sup>\n                      A modification patterns compared to those in normal brain tissues. We identified the m\n                      <jats:sup>6<\/jats:sup>\n                      A-modified pseudogene HSPA7 as a novel prognostic risk factor in GBM patients, with crucial roles in immunophenotype determination, stromal activation, and carcinogenic pathway activation. We confirmed that HSPA7 promoted macrophage infiltration and SPP1 expression\n                      <jats:italic>via<\/jats:italic>\n                      upregulating the YAP1 and LOX expression of glioblastoma stem cells (GSCs)\n                      <jats:italic>in vitro<\/jats:italic>\n                      and in our clinical GBM tumor samples. We also confirmed that knockdown of HSPA7 might increase the efficiency of anti-PD1 therapy utilizing the GBO model, highlighting its potential as a novel target for immunotherapy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our results indicated that HSPA7 could be a novel immunotherapy target for GBM patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2021.653711","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T08:18:50Z","timestamp":1626769130000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":46,"title":["The N6-Methyladenosine-Modified Pseudogene HSPA7 Correlates With the Tumor Microenvironment and Predicts the Response to Immune Checkpoint Therapy in Glioblastoma"],"prefix":"10.3389","volume":"12","author":[{"given":"Rongrong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouji","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qindong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaobo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,7,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-0491","article-title":"Immunotherapy for Glioblastoma: Playing Chess, Not Checkers","volume":"24","author":"Jackson","year":"2018","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0349-y","article-title":"Immune and Genomic Correlates of Response to Anti-PD-1 Immunotherapy in Glioblastoma","volume":"25","author":"Zhao","year":"2019","journal-title":"Nat Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00041","article-title":"Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities","volume":"9","author":"Daniel","year":"2019","journal-title":"Front Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-16-0575","article-title":"Immunogenomics of Hypermutated Glioblastoma: A Patient With Germline POLE Deficiency Treated With Checkpoint Blockade Immunotherapy","volume":"6","author":"Johanns","year":"2016","journal-title":"Cancer Discovery"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2016.66.6552","article-title":"Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency","volume":"34","author":"Bouffet","year":"2016","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2019.08.028","article-title":"Microglia\/Brain Macrophages as Central Drivers of Brain Tumor Pathobiology","volume":"104","author":"Gutmann","year":"2019","journal-title":"Neuron"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1016\/j.cell.2020.04.055","article-title":"Single-Cell Mapping of Human Brain Cancer Reveals Tumor-Specific Instruction of Tissue-Invading Leukocytes","volume":"181","author":"Friebel","year":"2020","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1016\/j.cell.2020.05.007","article-title":"Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells","volume":"181","author":"Klemm","year":"2020","journal-title":"Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0034-6","article-title":"RNA N-Methyladenosine Modification in Cancers: Current Status and Perspectives","volume":"28","author":"Deng","year":"2018","journal-title":"Cell Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-018-0040-8","article-title":"Dynamic Transcriptomic mA Decoration: Writers, Erasers, Readers and Functions in RNA Metabolism","volume":"28","author":"Yang","year":"2018","journal-title":"Cell Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.15382","article-title":"Prognostic Values of YTHDF1 Regulated Negatively by Mir-3436 in Glioma","volume":"24","author":"Xu","year":"2020","journal-title":"J Cell Mol Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3390\/cancers12030736","article-title":"The Emerging Roles of RNA Modifications in Glioblastoma","volume":"12","author":"Dong","year":"2020","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18632\/aging.101829","article-title":"mA RNA Methylation Regulators Contribute to Malignant Progression and Have Clinical Prognostic Impact in Gliomas","volume":"11","author":"Chai","year":"2019","journal-title":"Aging"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2017.351","article-title":"Essential Role of METTL3-Mediated mA Modification in Glioma Stem-Like Cells Maintenance and Radioresistance","volume":"37","author":"Visvanathan","year":"2018","journal-title":"Oncogene"},{"key":"B15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ccell.2017.02.013","article-title":"mA Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-Like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program","volume":"31","author":"Zhang","year":"2017","journal-title":"Cancer Cell"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/ni.3830","article-title":"The RNA Helicase DDX46 Inhibits Innate Immunity by Entrapping mA-Demethylated Antiviral Transcripts in the Nucleus","volume":"18","author":"Zheng","year":"2017","journal-title":"Nat Immunol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.immuni.2020.05.003","article-title":"mA Modification Prevents Formation of Endogenous Double-Stranded RNAs and Deleterious Innate Immune Responses During Hematopoietic Development","volume":"52","author":"Gao","year":"2020","journal-title":"Immunity"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-0916-x","article-title":"Anti-Tumour Immunity Controlled Through mRNA mA Methylation and YTHDF1 in Dendritic Cells","volume":"566","author":"Han","year":"2019","journal-title":"Nature"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/nature23450","article-title":"mA mRNA Methylation Controls T Cell Homeostasis by Targeting the IL-7\/STAT5\/SOCS Pathways","volume":"548","author":"Li","year":"2017","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/nature19342","article-title":"M(6)A RNA Methylation Promotes XIST-Mediated Transcriptional Repression","volume":"537","author":"Patil","year":"2016","journal-title":"Nature"},{"key":"B21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12943-019-1079-y","article-title":"Long Noncoding RNA GAS5 Inhibits Progression of Colorectal Cancer by Interacting With and Triggering YAP Phosphorylation and Degradation and is Negatively Regulated by the mA Reader YTHDF3","volume":"18","author":"Ni","year":"2019","journal-title":"Mol Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2020.02.004","article-title":"mA Modification in Coding and Non-Coding RNAs: Roles and Therapeutic Implications in Cancer","volume":"37","author":"Huang","year":"2020","journal-title":"Cancer Cell"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1126\/science.aad0095","article-title":"Genomic Correlates of Response to CTLA-4 Blockade in Metastatic Melanoma","volume":"350","author":"Van Allen","year":"2015","journal-title":"Sci (New York NY)"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.10.003","article-title":"Spatiotemporal Dynamics of Intratumoral Immune Cells Reveal the Immune Landscape in Human Cancer","volume":"39","author":"Bindea","year":"2013","journal-title":"Immunity"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.10.052","article-title":"Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies","volume":"17","author":"Bowman","year":"2016","journal-title":"Cell Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The Molecular Signatures Database (MSigDB) Hallmark Gene Set Collection","volume":"1","author":"Liberzon","year":"2015","journal-title":"Cell Syst"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a Reference Resource for Gene and Protein Annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature25501","article-title":"Tgf\u03b2 Attenuates Tumour Response to PD-L1 Blockade by Contributing to Exclusion of T Cells","volume":"554","author":"Mariathasan","year":"2018","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.7150\/thno.46176","article-title":"Macrophage Correlates With Immunophenotype and Predicts Anti-PD-L1 Response of Urothelial Cancer","volume":"10","author":"Zeng","year":"2020","journal-title":"Theranostics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-018-0339-5","article-title":"Neoadjuvant Nivolumab Modifies the Tumor Immune Microenvironment in Resectable Glioblastoma","volume":"25","author":"Schalper","year":"2019","journal-title":"Nat Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.cell.2019.11.036","article-title":"A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-Tumoral Heterogeneity","volume":"180","author":"Jacob","year":"2020","journal-title":"Cell"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5154.182416","article-title":"Biostatistics Series Module 3: Comparing Groups: Numerical Variables","volume":"61","author":"Hazra","year":"2016","journal-title":"Indian J Dermatol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.ccell.2017.06.003","article-title":"Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates With Immunological Changes in the Microenvironment","volume":"32","author":"Wang","year":"2017","journal-title":"Cancer Cell"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noq082","article-title":"Glioma Cancer Stem Cells Induce Immunosuppressive Macrophages\/Microglia","volume":"12","author":"Wu","year":"2010","journal-title":"Neuro-oncology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-18-0118","article-title":"Combined Blockade of IL6 and PD-1\/PD-L1 Signaling Abrogates Mutual Regulation of Their Immunosuppressive Effects in the Tumor Microenvironment","volume":"78","author":"Tsukamoto","year":"2018","journal-title":"Cancer Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.ccr-18-1627","article-title":"Brain Tumor Microenvironment and Host State: Implications for Immunotherapy","volume":"25","author":"Tomaszewski","year":"2019","journal-title":"Clin Cancer Res: Off J Am Assoc Cancer Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/nature21349","article-title":"Elements of Cancer Immunity and the Cancer-Immune Set Point","volume":"541","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"B38","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","article-title":"Estimating The\u00a0Population Abundance of Tissue-Infiltrating Immune and Stromal Cell Populations Using Gene Expression","volume":"17","author":"Becht","year":"2016","journal-title":"Genome Biol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7497\/j.issn.2095-3941.2015.0015","article-title":"Mechanistic Basis and Clinical Relevance of the Role of Transforming Growth Factor-\u03b2 in Cancer","volume":"12","author":"Lin","year":"2015","journal-title":"Cancer Biol Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2008.07.001","article-title":"TGFbeta in Cancer","volume":"134","author":"Massagu\u00e9","year":"2008","journal-title":"Cell"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/nri2808","article-title":"The Polarization of Immune Cells in the Tumour Environment by TGFbeta","volume":"10","author":"Flavell","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-14-0275","article-title":"Active CREB1 Promotes a Malignant Tgf\u03b22 Autocrine Loop in Glioblastoma","volume":"4","author":"Rod\u00f3n","year":"2014","journal-title":"Cancer Discov"},{"key":"B43","doi-asserted-by":"publisher","first-page":"e80747","DOI":"10.1371\/journal.pone.0080747","article-title":"PaGenBase: A Pattern Gene Database for the Global and Dynamic Understanding of Gene Function","volume":"8","author":"Pan","year":"2013","journal-title":"PloS One"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkx1013","article-title":"TRRUST V2: An Expanded Reference Database of Human and Mouse Transcriptional Regulatory Interactions","volume":"46","author":"Han","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1038\/s41421-018-0019-0","article-title":"VIRMA Mediates Preferential mA mRNA Methylation in 3\u2019UTR and Near Stop Codon and Associates With Alternative Polyadenylation","volume":"4","author":"Yue","year":"2018","journal-title":"Cell Discov"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1038\/cr.2014.3","article-title":"Mammalian WTAP is a Regulatory Subunit of the RNA N6-Methyladenosine Methyltransferase","volume":"24","author":"Ping","year":"2014","journal-title":"Cell Res"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.1432","article-title":"A METTL3-METTL14 Complex Mediates Mammalian Nuclear RNA N6-Adenosine Methylation","volume":"10","author":"Liu","year":"2014","journal-title":"Nat Chem Biol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12943-018-0857-2","article-title":"FBXW7: A Critical Tumor Suppressor of Human Cancers","volume":"17","author":"Yeh","year":"2018","journal-title":"Mol Cancer"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.cd-19-1416","article-title":"Inactivation of Fbxw7 of Impairs dsRNA Sensing and Confers Resistance to PD-1 Blockade","volume":"10","author":"Gstalder","year":"2020","journal-title":"Cancer Discov"},{"key":"B50","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1007\/s10120-020-01088-y","article-title":"Resistance to FGFR1-Targeted Therapy Leads to Autophagy via TAK1\/AMPK Activation in Gastric Cancer","volume":"23","author":"Peng","year":"2020","journal-title":"Gastric Cancer: Off J Int Gastric Cancer Assoc Jpn Gastric Cancer Assoc"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/2326-6066.cir-18-0595","article-title":"The Combined Effect of FGFR Inhibition and PD-1 Blockade Promotes Tumor-Intrinsic Induction of Antitumor Immunity","volume":"7","author":"Palakurthi","year":"2019","journal-title":"Cancer Immunol Res"},{"key":"B52","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1016\/j.ccell.2019.05.003","article-title":"Symbiotic Macrophage-Glioma Cell Interactions Reveal Synthetic Lethality in PTEN-Null Glioma","volume":"35","author":"Chen","year":"2019","journal-title":"Cancer Cell"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0312-8","article-title":"Tumor Mutational Load Predicts Survival After Immunotherapy Across Multiple Cancer Types","volume":"51","author":"Samstein","year":"2019","journal-title":"Nat Genet"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2209-9","article-title":"Mechanisms and Therapeutic Implications of Hypermutation in Gliomas","volume":"580","author":"Touat","year":"2020","journal-title":"Nature"},{"key":"B55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s12943-020-01170-0","article-title":"mA Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Gastric Cancer","volume":"19","author":"Zhang","year":"2020","journal-title":"Mol Cancer"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0433-y","article-title":"Mechanisms of Immunotherapy Resistance: Lessons From Glioblastoma","volume":"20","author":"Jackson","year":"2019","journal-title":"Nat Immunol"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-018-0003-5","article-title":"Current State of Immunotherapy for Glioblastoma","volume":"15","author":"Lim","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151193","article-title":"Tumor Macrophages are Pivotal Constructors of Tumor Collagenous Matrix","volume":"213","author":"Afik","year":"2016","journal-title":"J Exp Med"},{"key":"B59","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies in Colon Cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2016.04.084","article-title":"Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis","volume":"15","author":"Georgoudaki","year":"2016","journal-title":"Cell Rep"},{"key":"B61","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1038\/s41419-019-1894-5","article-title":"CCT3 Acts Upstream of YAP and TFCP2 as a Potential Target and Tumour Biomarker in Liver Cancer","volume":"10","author":"Liu","year":"2019","journal-title":"Cell Death Dis"},{"key":"B62","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.tibs.2017.11.009","article-title":"Hippo Signaling in the Immune System","volume":"43","author":"Zhang","year":"2018","journal-title":"Trends Biochem Sci"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1074\/mcp.RA118.000644","article-title":"The Impact of Oncogenic EGFRvIII on the Proteome of Extracellular Vesicles Released From Glioblastoma Cells","volume":"17","author":"Choi","year":"2018","journal-title":"Mol Cell Proteomics: MCP"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-019-0168-y","article-title":"YAP and TAZ: A Signalling Hub of the Tumour Microenvironment","volume":"19","author":"Zanconato","year":"2019","journal-title":"Nat Rev Cancer"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1200\/jco.2017.75.7740","article-title":"Alterations in DNA Damage Response and Repair Genes as Potential Marker of Clinical Benefit From PD-1\/PD-L1 Blockade in Advanced Urothelial Cancers","volume":"36","author":"Teo","year":"2018","journal-title":"J Clin Oncol: Off J Am Soc Clin Oncol"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2015.07.009","article-title":"Defects in DNA Repair Genes Predict Response to Neoadjuvant Cisplatin-Based Chemotherapy in Muscle-Invasive Bladder Cancer","volume":"68","author":"Plimack","year":"2015","journal-title":"Eur Urol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.653711\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T08:18:54Z","timestamp":1626769134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.653711\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,20]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2021.653711"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.653711","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,20]]},"article-number":"653711"}}